Product Profiles Insulin Antidiabetics Key developers compete for basal insulins market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Cancer Drug News 23 FEBRUARY 2015

Cancer Drug News 23 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - New ACA Initiative To Be Tested To Manage Rising Cancer Costs And Improve Cancer Care Industry Brief - Eagle Licenses Teva To Commercialise Bendamustine Rapid Infusion In US Industry Brief - Imbruvica Shows Efficacy/Tolerability In Heavily Treated CLL Patients Following Allo-HCT ...

Industries: Drug and Medication

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2015
  • 94 pages

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections downwards, our view that Slovenia's drug industry is one of the most stable in the region remains. ...

Industries: Drug and Medication | Countries: Slovenia

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2015
  • 110 pages

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft structural healthcare reforms which were pulled in January – but were nevertheless expected to ...

Industries: Drug and Medication | Countries: Romania

Canada Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Canada Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2015
  • 101 pages

BMI View: With Canada’s economy set to weather the external storm, the outlook for the country’s pharmaceutical industry looks relatively stable. Over the longer-term an ageing population in this already mature industry should support spending. We also maintain it is highly unlikely the Canadian ...

Industries: Drug and Medication | Countries: Canada

Buderim Ginger Limited

Buderim Ginger Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 54 pages

A textual analysis of the financial results for Buderim Ginger Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication | Countries: Australia

Cholestyramine Europe Report

Cholestyramine Europe Report

  • $ 2 969
  • Industry report
  • by PureData
  • February 2015
  • 1957 pages

CHOLESTYRAMINE EUROPE REPORT The Cholestyramine Europe Report gives Market Consumption / Products / Services for 44 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered include: Albania, Andorra, Armenia, Austria, ...

Industries: Drug and Medication | Countries: Europe

Anti-Infective Drug News 23 FEBRUARY 2015

Anti-Infective Drug News 23 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 16 pages

Industry Trend Analysis - HIV Market Set To Expand Gradually; Gilead To Uphold Leadership Despite ViiV Industry Brief - Affinivax/PATH Collaborate To Advance Vaccine Candidate For Pneumococcus Industry Brief - Valneva Completes Acquisition Of Dukoral Vaccine From Crucell Industry Brief - NICE Sets Out ...

Industries: Drug and Medication | Countries: United States, Canada, Japan, India

Cholestyramine Middle East Report

Cholestyramine Middle East Report

  • $ 2 969
  • Industry report
  • by PureData
  • February 2015
  • 1931 pages

CHOLESTYRAMINE MIDDLE EAST REPORT The Cholestyramine Middle East Report gives Market Consumption / Products / Services for 19 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered include: Afghanistan, Azerbaijan, Bahrain, ...

Industries: Drug and Medication

Cholestyramine Oceania Report

Cholestyramine Oceania Report

  • $ 2 969
  • Industry report
  • by PureData
  • February 2015
  • 1941 pages

CHOLESTYRAMINE OCEANIA REPORT The Cholestyramine Oceania Report gives Market Consumption / Products / Services for 17 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered include: American Samoa, Australia, Fiji, French ...

Industries: Drug and Medication | Countries: Oceania

Cholestyramine South America Report

Cholestyramine South America Report

  • $ 2 969
  • Industry report
  • by PureData
  • February 2015
  • 1972 pages

CHOLESTYRAMINE SOUTH AMERICA REPORT The Cholestyramine South America Report gives Market Consumption / Products / Services for 13 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered include: Argentina, Bolivia, Brazil, ...

Industries: Drug and Medication | Countries: South America

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.